A new study by a team of scientists Faculty of Health Sciences, the University of Nairobi and from multiple institutions in Kenya and the United States, led by James Mburu Kangethe (PhD Scholar from the Department of Medical Microbiology & Immunology and a CARTA Fellow), who is co-supervised by Dr. Stephen Gichuhi and Dr.

KAVI-Institute of Clinical Research (KAVI-ICR) was awarded the 2022 International AIDS Vaccine Initiative (IAVI) External Quality Assessment (EQA) Awards For Tier 1 and Tier 2. This is the second year running that the Institute has won this prestigious award. It recognises the best performing laboratories amongst their Clinical Research Centres in Africa. The Institute at the University of Nairobi, KNH Campus was first among Tier 1 and the Kangemi site among Tier 2.